| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |